Results 71 to 80 of about 854 (118)

Treatment of unresolved pneumonia with streptokinase and streptodornase

American Journal of Medicine, 1952
Abstract 1.1. A case of unresolved pneumonia was treated by endobronchial instillation of streptokinase and streptodornase. ∗ ∗The Streptokinase and Streptodornase was supplied by the Lederle Laboratories Division, American Cyanamid Co., New York, N. Y. 2.2. The enzymes appeared to hasten resolution by liquefying fibrinopurulent material within the
J J, MUENSTER, I J, FLANCE, B, SWEENEY
exaly   +3 more sources

REACTION TO STREPTOKINASE AND STREPTODORNASE

JAMA - Journal of the American Medical Association, 1952
To the Editor: —The unusual reaction to the intrapleural administration of streptokinase and streptodornase described by Baum and Oransky inThe Journal, July 12, 1952, page 1012, has been observed although not reported previously (Miller and Long: U. S. Armed Forces M. J. 3: 1061 [July] 1952).
exaly   +2 more sources

Streptokinase/Streptodornase for Skin Testing

New England Journal of Medicine, 1979
H K, Steinman, P G, Tuteur
exaly   +3 more sources

STREPTOKINASE AND STREPTODORNASE IN THE TREATMENT OF SURGICAL INFECTIONS

Lancet, The, 1953
P H Long
exaly   +3 more sources

STREPTOKINASE AND STREPTODORNASE

Lancet, The, 1953
exaly   +2 more sources

STREPTOKINASE AND STREPTODORNASE IN INFLAMMATORY ŒDEMA

Lancet, The, 1956
exaly   +2 more sources

TREATMENT OF THROMBOPHLEBITIS WITH STREPTOKINASE-STREPTODORNASE

Journal of the American Medical Association, 1960
The buccal administration of streptokinasestreptodornase was tried in the treatment of a test group of 52 patients who had superficial thrombophlebitis as a complication after venoclysis. A contratest group of 22 patients, who received general treatment but neither the drugs nor a placebo, were observed for comparison.
H L, DEATON, W G, ANLYAN
openaire   +2 more sources

CLINICAL EXPERIENCE WITH STREPTOKINASE AND STREPTODORNASE

Journal of the American Medical Association, 1951
In a series of laboratory and clinical investigations, which have been in progress for about 20 years, Tillett and his associates 1 have demonstrated that the catalytic agent streptokinase and the enzyme desoxyribonuclease, or streptodornase, which are produced in abundance during the active growth of certain strains of beta hemolytic streptococci ...
J M, MILLER, M, GINSBERG, R J, LIPIN, P H, LONG   +3 more
openaire   +2 more sources

The Use of Streptokinase-Streptodornase on Surface Lesions

Archives of Surgery, 1955
In 1948, Tillet and Sherry published a report 1 on the clinical use of streptokinase and streptodornase for enzymatic debridement. Since then, many papers have appeared which have demonstrated the therapeutic effectiveness of these agents in a variety of clinical conditions. Despite this large and ever growing literature, it is felt that the following
C D, COOPER, W E, WACKER, M J, ROMANSKY
openaire   +2 more sources

STREPTOKINASE AND STREPTODORNASE IN THE TREATMENT OF DIABETIC GANGRENE

Archives of Internal Medicine, 1951
GANGRENE is one of the commonest and most serious complications of diabetes mellitus. Eliason 1 reported that 13 per cent of 1,305 diabetics admitted to the Philadelphia General Hospital from 1930 to 1933 had gangrene requiring surgical treatment.
Mcvay, Leon V., Sprunt, Douglas H.
openaire   +3 more sources